Coloplast Statistics

Total Valuation

Coloplast has a market cap or net worth of GBP 18.68 billion. The enterprise value is 21.41 billion.

Market Cap	18.68B
Enterprise Value	21.41B

Important Dates

The next estimated earnings date is Tuesday, May 6, 2025.

Earnings Date	May 6, 2025
Ex-Dividend Date	Dec 6, 2024

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	+2.97%
Shares Change (QoQ)	+0.22%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	141.39M

Valuation Ratios

The trailing PE ratio is 34.50.

PE Ratio	34.50
Forward PE	n/a
PS Ratio	6.14
PB Ratio	10.90
P/TBV Ratio	n/a
P/FCF Ratio	94.81
P/OCF Ratio	56.44
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 21.79, with an EV/FCF ratio of 108.66.

EV / Earnings	39.53
EV / Sales	6.82
EV / EBITDA	21.79
EV / EBIT	25.29
EV / FCF	108.66

Financial Position

The company has a current ratio of 0.81, with a Debt / Equity ratio of 1.60.

Current Ratio	0.81
Quick Ratio	0.49
Debt / Equity	1.60
Debt / EBITDA	2.88
Debt / FCF	13.93
Interest Coverage	8.97

Financial Efficiency

Return on equity (ROE) is 31.94% and return on invested capital (ROIC) is 12.02%.

Return on Equity (ROE)	31.94%
Return on Assets (ROA)	9.54%
Return on Invested Capital (ROIC)	12.02%
Return on Capital Employed (ROCE)	20.80%
Revenue Per Employee	183,056
Profits Per Employee	32,570
Employee Count	16,639
Asset Turnover	0.57
Inventory Turnover	2.48

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -24.09% in the last 52 weeks. The beta is 0.60, so Coloplast's price volatility has been lower than the market average.

Beta (5Y)	0.60
52-Week Price Change	-24.09%
50-Day Moving Average	741.09
200-Day Moving Average	837.99
Relative Strength Index (RSI)	53.34
Average Volume (20 Days)	32,686

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Coloplast had revenue of GBP 3.04 billion and earned 541.57 million in profits. Earnings per share was 2.41.

Revenue	3.04B
Gross Profit	2.05B
Operating Income	820.45M
Pretax Income	732.96M
Net Income	541.57M
EBITDA	920.47M
EBIT	820.45M
Earnings Per Share (EPS)	2.41

Full Income Statement

Balance Sheet

The company has 100.46 million in cash and 2.75 billion in debt, giving a net cash position of -2.64 billion.

Cash & Cash Equivalents	100.46M
Total Debt	2.75B
Net Cash	-2.64B
Net Cash Per Share	n/a
Equity (Book Value)	1.71B
Book Value Per Share	7.61
Working Capital	-266.02M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 331.00 million and capital expenditures -133.95 million, giving a free cash flow of 197.05 million.

Operating Cash Flow	331.00M
Capital Expenditures	-133.95M
Free Cash Flow	197.05M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 67.45%, with operating and profit margins of 26.95% and 17.79%.

Gross Margin	67.45%
Operating Margin	26.95%
Pretax Margin	24.08%
Profit Margin	17.79%
EBITDA Margin	30.24%
EBIT Margin	26.95%
FCF Margin	6.47%

Dividends & Yields

This stock pays an annual dividend of 2.47, which amounts to a dividend yield of 0.35%.

Dividend Per Share	2.47
Dividend Yield	0.35%
Dividend Growth (YoY)	1.76%
Years of Dividend Growth	9
Payout Ratio	101.47%
Buyback Yield	-2.97%
Shareholder Yield	-2.61%
Earnings Yield	2.90%
FCF Yield	1.05%

Dividend Details

Stock Splits

The last stock split was on December 19, 2012. It was a forward split with a ratio of 5.

Last Split Date	Dec 19, 2012
Split Type	Forward
Split Ratio	5

Scores

Coloplast has an Altman Z-Score of 5.07.

Altman Z-Score	5.07
Piotroski F-Score	n/a